Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Baxter International Inc. stock logo
BAX
Baxter International
$28.07
+0.6%
$30.37
$26.25
$40.49
$14.39B0.614.34 million shs1,028 shs
Biodesix, Inc. stock logo
BDSX
Biodesix
$0.31
+0.5%
$0.30
$0.17
$2.04
$45.73M0.974.36 million shs25,032 shs
Elevance Health, Inc. stock logo
ELV
Elevance Health
$288.83
-4.5%
$374.07
$285.70
$567.26
$65.12B0.61.65 million shs14,244 shs
Integer Holdings Corporation stock logo
ITGR
Integer
$115.25
-1.6%
$119.76
$104.93
$146.36
$4.04B0.98388,320 shs554,711 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Baxter International Inc. stock logo
BAX
Baxter International
-1.69%-5.90%-6.79%-3.52%-21.91%
Biodesix, Inc. stock logo
BDSX
Biodesix
+1.34%+1.70%+9.17%-43.42%-82.65%
Elevance Health, Inc. stock logo
ELV
Elevance Health
-12.53%-12.74%-19.67%-29.01%-42.07%
Integer Holdings Corporation stock logo
ITGR
Integer
-2.03%-5.77%-3.59%-1.90%-7.73%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Baxter International Inc. stock logo
BAX
Baxter International
4.6122 of 5 stars
3.22.01.74.01.91.72.5
Biodesix, Inc. stock logo
BDSX
Biodesix
4.0884 of 5 stars
4.45.00.00.02.72.50.6
Elevance Health, Inc. stock logo
ELV
Elevance Health
4.9633 of 5 stars
4.43.04.20.03.12.53.8
Integer Holdings Corporation stock logo
ITGR
Integer
3.8955 of 5 stars
4.51.00.00.02.92.51.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Baxter International Inc. stock logo
BAX
Baxter International
2.44
Hold$36.3829.60% Upside
Biodesix, Inc. stock logo
BDSX
Biodesix
2.80
Moderate Buy$1.75460.90% Upside
Elevance Health, Inc. stock logo
ELV
Elevance Health
2.75
Moderate Buy$451.5356.33% Upside
Integer Holdings Corporation stock logo
ITGR
Integer
3.00
Buy$146.2526.90% Upside

Current Analyst Ratings Breakdown

Latest ITGR, BDSX, ELV, and BAX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/18/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Market Perform$510.00 ➝ $310.00
7/18/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$428.00 ➝ $316.00
7/16/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$500.00 ➝ $440.00
7/15/2025
Baxter International Inc. stock logo
BAX
Baxter International
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$28.00 ➝ $27.00
7/15/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$478.00 ➝ $400.00
7/14/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$555.00 ➝ $484.00
7/9/2025
Baxter International Inc. stock logo
BAX
Baxter International
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$34.00 ➝ $32.00
7/9/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$480.00 ➝ $434.00
7/8/2025
Baxter International Inc. stock logo
BAX
Baxter International
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$44.00 ➝ $42.00
6/9/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$510.00 ➝ $500.00
6/4/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$478.00
(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Baxter International Inc. stock logo
BAX
Baxter International
$10.64B1.35$4.70 per share5.97$13.76 per share2.04
Biodesix, Inc. stock logo
BDSX
Biodesix
$71.32M0.64N/AN/A$0.14 per share2.23
Elevance Health, Inc. stock logo
ELV
Elevance Health
$177.01B0.37$32.86 per share8.79$178.62 per share1.62
Integer Holdings Corporation stock logo
ITGR
Integer
$1.72B2.34$8.76 per share13.15$48.27 per share2.39
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Baxter International Inc. stock logo
BAX
Baxter International
-$649M-$1.10N/A10.280.83-4.71%17.24%5.12%8/5/2025 (Estimated)
Biodesix, Inc. stock logo
BDSX
Biodesix
-$42.93M-$0.29N/AN/AN/A-54.28%-167.28%-39.96%8/6/2025 (Estimated)
Elevance Health, Inc. stock logo
ELV
Elevance Health
$5.98B$25.6311.257.400.883.23%18.61%6.80%N/A
Integer Holdings Corporation stock logo
ITGR
Integer
$119.90M$2.1154.8417.331.014.38%11.95%6.04%7/24/2025 (Estimated)

Latest ITGR, BDSX, ELV, and BAX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
Biodesix, Inc. stock logo
BDSX
Biodesix
-$0.07N/AN/AN/A$18.47 millionN/A
8/5/2025Q2 2025
Baxter International Inc. stock logo
BAX
Baxter International
$0.60N/AN/AN/A$2.82 billionN/A
7/24/2025Q2 2025
Integer Holdings Corporation stock logo
ITGR
Integer
$1.57N/AN/AN/A$464.37 millionN/A
7/17/2025Q2 2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
$9.30$8.84-$0.46$7.72$48.26 billion$49.42 billion
5/13/2025Q1 2025
Biodesix, Inc. stock logo
BDSX
Biodesix
-$0.08-$0.08N/A-$0.08$19.50 million$17.96 million
5/1/2025Q1 2025
Baxter International Inc. stock logo
BAX
Baxter International
$0.48$0.62+$0.14$0.25$2.59 billion$2.63 billion
4/24/2025Q1 2025
Integer Holdings Corporation stock logo
ITGR
Integer
$1.27$1.31+$0.04-$0.66$428.51 million$437.39 million
4/22/2025Q1 2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
$10.60$11.97+$1.37$9.61$46.26 billion$48.77 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Baxter International Inc. stock logo
BAX
Baxter International
$0.682.42%N/AN/A N/A
Biodesix, Inc. stock logo
BDSX
Biodesix
N/AN/AN/AN/AN/A
Elevance Health, Inc. stock logo
ELV
Elevance Health
$6.842.37%N/A26.69%14 Years
Integer Holdings Corporation stock logo
ITGR
Integer
N/AN/AN/AN/AN/A

Latest ITGR, BDSX, ELV, and BAX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/14/2025
Baxter International Inc. stock logo
BAX
Baxter International
quarterly$0.172.38%8/29/20258/29/202510/1/2025
5/6/2025
Baxter International Inc. stock logo
BAX
Baxter International
quarterly$0.172.27%5/30/20255/30/20257/1/2025
4/23/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
quarterly$1.711.6%6/10/20256/10/20256/25/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Baxter International Inc. stock logo
BAX
Baxter International
1.33
2.02
1.40
Biodesix, Inc. stock logo
BDSX
Biodesix
3.32
2.22
2.22
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.66
1.43
1.43
Integer Holdings Corporation stock logo
ITGR
Integer
0.78
3.40
2.14

Institutional Ownership

CompanyInstitutional Ownership
Baxter International Inc. stock logo
BAX
Baxter International
90.19%
Biodesix, Inc. stock logo
BDSX
Biodesix
20.96%
Elevance Health, Inc. stock logo
ELV
Elevance Health
89.24%
Integer Holdings Corporation stock logo
ITGR
Integer
99.29%

Insider Ownership

CompanyInsider Ownership
Baxter International Inc. stock logo
BAX
Baxter International
0.21%
Biodesix, Inc. stock logo
BDSX
Biodesix
30.10%
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.29%
Integer Holdings Corporation stock logo
ITGR
Integer
2.16%
CompanyEmployeesShares OutstandingFree FloatOptionable
Baxter International Inc. stock logo
BAX
Baxter International
38,000513.17 million512.10 millionOptionable
Biodesix, Inc. stock logo
BDSX
Biodesix
220146.56 million102.45 millionOptionable
Elevance Health, Inc. stock logo
ELV
Elevance Health
104,200225.93 million225.28 millionOptionable
Integer Holdings Corporation stock logo
ITGR
Integer
11,00034.89 million34.14 millionOptionable

Recent News About These Companies

Brokerages Set Integer Holdings Corporation (NYSE:ITGR) PT at $145.00
Integer (ITGR) to Release Earnings on Thursday
Integer Holdings (ITGR) Gets a Buy from Citi
Integer appoints former iRhythm CEO to board
Integer Appoints Michael Coyle to Board of Directors

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Baxter International stock logo

Baxter International NYSE:BAX

$28.07 +0.18 (+0.63%)
As of 09:39 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Biodesix stock logo

Biodesix NASDAQ:BDSX

$0.31 +0.00 (+0.45%)
As of 09:38 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Elevance Health stock logo

Elevance Health NYSE:ELV

$288.83 -13.62 (-4.50%)
As of 09:39 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Integer stock logo

Integer NYSE:ITGR

$115.24 -1.89 (-1.61%)
As of 09:38 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.